Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy

Simple item page
dc.contributor.authorCarlos A. Morillo
dc.contributor.authorJosé Antônio Marin‐Neto
dc.contributor.authorÁlvaro Avezum
dc.contributor.authorSergio Sosa‐Estáni
dc.contributor.authorAnis Rassi
dc.contributor.authorFernando Rosas
dc.contributor.authorErick Villena
dc.contributor.authorRoberto Quiroz
dc.contributor.authorRina Bonilla
dc.contributor.authorConstança Britto
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:50:00Z
dc.date.available2026-03-22T13:50:00Z
dc.date.issued2015
dc.descriptionCitaciones: 1009
dc.description.abstractTrypanocidal therapy with benznidazole in patients with established Chagas' cardiomyopathy significantly reduced serum parasite detection but did not significantly reduce cardiac clinical deterioration through 5 years of follow-up. (Funded by the Population Health Research Institute and others; ClinicalTrials.gov number, NCT00123916; Current Controlled Trials number, ISRCTN13967269.).
dc.identifier.doi10.1056/nejmoa1507574
dc.identifier.urihttps://doi.org/10.1056/nejmoa1507574
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/42983
dc.language.isoen
dc.publisherMassachusetts Medical Society
dc.relation.ispartofNew England Journal of Medicine
dc.sourcePopulation Health Research Institute
dc.subjectBenznidazole
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectPlacebo
dc.subjectHazard ratio
dc.subjectOdds ratio
dc.subjectChagas disease
dc.subjectCardiomyopathy
dc.subjectHeart transplantation
dc.subjectHeart failure
dc.titleRandomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
dc.typearticle

Files

Collections

Artículo Científico Publicado